Table 2 Demographic data and clinical characteristics of subjects in the study
Characteristics | Patients with SLE (n = 31) | HCs (n = 10) | P-value |
|---|---|---|---|
Age (Mean ± SD) (years) | 32.84 ± 14.14 | 31.60 ± 5.52 | 0.70 |
Sex (% Female) | 0.87 | 0.90 | 0.92 |
Height (cm) | 160.23 ± 7.57 | 164.00 ± 5.14 | 0.42 |
Weight (kg) | 55.31 ± 10.45 | 58.00 ± 5.80 | 0.33 |
Disease Activity (Mean SLEDAI ± SD) | 9.68 ± 7.08 | / | / |
SLEDAI ≤ 10 (%) | 22.00 (70.97%) | / | / |
SLEDAI > 10 (%) | 9.00 (29.03%) | / | / |
C3 (Mean ± SD) | 0.71 ± 0.33 | / | / |
C4 (Mean ± SD) | 0.14 ± 0.09 | / | / |
ANA Positive (%) | 1 | / | / |
Anti-dsDNA Antibody Positive (%) | 0.55 | / | / |
Anti-Sm Antibody Positive (%) | 0.19 | / | / |
Anti-Nucleosome Antibody Positive (%) | 0.55 | / | / |